Neocol Appoints Ross Freedman to Board of Directors to Support Growth
Co-Founder and Former CEO of Rightpoint brings more than 20 years of relevant leadership experience to Board LOS ANGELES, Nov. 10, 2025 /PRNewswire/ — Neocol,... Read more.
Rebuilding the Tumor Microenvironment for In Vitro Discovery, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how modeling the tumor microenvironment in vitro supports next-generation cancer research and drug discovery. Attendees will understand... Read more.
Global OEMs Will Launch First VA7000-Based Endoscopes, Signaling Strong Momentum for Valens Semiconductor’s Medical Imaging Offering
Three new endoscopes set to launch, including an innovative laparoscope, a 3D imaging solution for robotic surgeries, and the first single-use colonoscope with 4K... Read more.
BitMine Immersion (BMNR) Announces ETH Holdings Reaching 3.5 Million Tokens and Total Crypto and Cash Holdings of $13.2 Billion
BitMine Crypto + Cash Holdings + “Moonshots” total $13.2 billion, including 3.5 million ETH tokens, unencumbered cash of $398 million, and other crypto... Read more.
Mynd.ai’s Promethean brand Forges Strategic Relationship with Augment Me to Advance AI-Powered Learning
SEATTLE, Nov. 10, 2025 /PRNewswire/ — Mynd.ai, Inc (“Mynd” or the Company) (NYSE American: MYND) today announced that its subsidiary, Promethean,... Read more.
Abu Dhabi Investment Office announces 29 strategic partnerships to accelerate commercialisation of autonomous mobility
ABU DHABI, UAE, Nov. 10, 2025 /PRNewswire/ — Abu Dhabi Investment Office (ADIO) has announced 29 commercial deployment agreements for autonomous mobility... Read more.
Personalized Cancer Insights, Grounded in Biology, DNA/RNA & AI Delivered in an Average of 10 Days
In cancer care, every day that passes can cost a life. First Ascent Biomedical is racing against that clock. By testing a patient’s live cancer cells outside... Read more.
Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting
– Data demonstrates ofirnoflast’s efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – – A novel mechanism... Read more.
Vascarta and CUNY Report Preclinical Breakthrough in Glioblastoma Treatment
SUMMIT, N.J., Nov. 10, 2025 /PRNewswire/ — Vascarta Inc., a healthspan focused, clinical stage biopharmaceutical company advancing safe, patient friendly therapies... Read more.
Option Circle Unveils Vision for Next-Gen, AI-Driven, Fully Autonomous Regime-Based Trading Platform
Pioneering the Future of Trading Through Intelligent, Data-Driven Automation SAN JOSE, Calif., Nov. 10, 2025 /PRNewswire/ — Option Circle, a leading platform... Read more.